<!DOCTYPE html>
<html>
<head>
<title>12_1_MASTER_ALEXION_P03_T05_S02</title>
<meta name="viewport" content="user-scalable=no, width=device-width, initial-scale=1.0, maximum-scale=1.0"/>
<meta name="apple-mobile-web-app-capable" content="yes" />
<meta name="format-detection" content="telephone=no" />


<link href="../global/css/font.css" type="text/css" rel="stylesheet">
<link href="../global/css/global.css" type="text/css" rel="stylesheet">
<link href="css/main.css" type="text/css" rel="stylesheet">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body>
<div id="container">
<!--menu top-->

    <div class="logo"></div>
    <!--end elements-->
    <div id="main_container" class="bg_blue">
      <div class="claim">The balanced approach that helps<br>
        improve upper-GI<sup>§</sup> tolerability.<sup>†</sup></div>
      <div class="title_left brown Helvetica_Round_Bold">
        <i18n id="v2_txt1">VIMOVO demonstrates 
          significantly better upper-GI 
          tolerability vs EC naproxen.<sup>1</sup></i18n>
      </div>
      <div class="percent Helvetica_Round_Bold brown">
        <i18n id="v2_txt2">41%</i18n>
      </div>
      <div class="percent_txt HelveticaLTStd_Roman">
        <i18n id="v2_txt3"><span class="Helvetica_Round_Bold grey">improvement in 
          heartburn resolution.</span><br>
          <br>
          VIMOVO showed a 41% 
          improvement in heartburn
          resolution vs EC naproxen 
          at 6 months based upon a
          predefined, patient-reported 
          heartburn assessment.</i18n>
      </div>
      <div class="title_chart HelveticaLTStd_Roman">
        <i18n id="v6_txt4"><span>Heartburn - free at 6 months</span><br>
          <span>(% of patients)</span></i18n>
      </div>
    
    <div class="chart"></div>
    <div class="shadow"></div>
    <div class="chart_colum"></div>
    <div class="number"></div>
    
    <div class="text_bot_chart grey">
      <ul>
        <li>
          <i18n id="txt7"><span class="blue Helvetica_Round_Bold">VIMOVO</span> (n = 177)<br>
            (500mg/20mg BID)<br>
            <span class="Helvetica_Round_Bold">EC naproxen (n = 115)</span><br>
            (500mg BID)</i18n>
        </li>
      </ul>
    </div>
    <div class="right_colum">
      <ul>
        <li>
          <i18n id="txt10">p < 0.001 VIMOVO vs EC naproxen</i18n>
        </li>
      </ul>
    </div>
    <div class="text_month Helvetica_Round_Bold">
      <ul>
        <li>
          <i18n id="v2_txt13">Results from a second study demonstrated similar results:</i18n>
        </li>
      </ul>
    </div>
    <div class="text_detail HelveticaLTStd_Roman">
      <ul>
        <li>
          <i18n id="v2_txt14">- Month 1: VIMOVO 62.2% vs EC naproxen 48.4%, p < 0.05</i18n>
        </li>
        <li>
          <i18n id="v2_txt15">- Month 3: VIMOVO 68.5% vs EC naproxen 46.4%, p < 0.01</i18n>
        </li>
        <li>
          <i18n id="v2_txt16">- Month 6: VIMOVO 72.3% vs EC naproxen 51.2%, p < 0.01</i18n>
        </li>
        <li>
          <i18n id="v2_txt17">&nbsp;&nbsp;n = 141 VIMOVO, n = 121 EC naproxen</i18n>
        </li>
      </ul>
    </div>
    </div>
    
    <!--End #main_container -->
    <div class="ref_wrapper" id="ref_all"></div>
    <div id="scroll-wrapper" class="scroll_ref">
      <div id="scroller">
        <h1 class="brown Helvetica_Round_Bold">
          <i18n id="v2_v1_S007_ref">References:</i18n>
        </h1>
        <div class="ref HelveticaLTStd_Roman"> <span class="ref_number">1.</span>
          <i18n id="v2_v1_S007_ref_txt0">Goldstein, JL, et al. <span class="HelveticaNeueLTStd_it">Aliment Pharmacol Ther</span> 2010; 32(3): 401-413.</i18n>
        </div>
        <div class="ref HelveticaLTStd_Roman"> <span class="ref_number">2.</span>
          <i18n id="v2_v1_S007_ref_txt1">VIMOVO Summary of Product Information. </i18n>
        </div>
        <div class="ref HelveticaLTStd_Roman"> <span class="ref_number">§</span>
          <i18n id="v2_v1_S007_ref_txt5">Gastrointestinal</i18n>
        </div>
        <!--end Ref-->
        <div class="ref HelveticaLTStd_Roman"> <span class="ref_number">†</span>
          <i18n id="v2_v1_S007_ref_txt7">Helping to improve upper-GI tolerability is evidenced by fewer 
    upper-GI ulcers, fewer discontinuations due to upper-GI AEs 
    including duodenal ulcers, and less abdominal discomfort over a 
    6-month period as measured by dyspepsia symptoms versus 
    EC naproxen.</i18n>
        </div>
      </div>
      <div class="close"><span class="right"></span></div>
      <div class="arrow_ref"></div>
    </div>
    
    <!--End area for ref-->
    
    <div class="info_wrapper" id="info_all"></div>
    <div id="scroll-wrapper" class="scroll_info">
      <div id="scroller">
        <h1 class="brown Helvetica_Round_Bold">
          <i18n id="v2_v1_S007_ref2">Pivotal Trials:</i18n>
        </h1>
        <div class="ref HelveticaLTStd_Roman ref_1">
          <i18n id="v1_info1">Having a medical condition expected to require daily NSAID therapy for at least 6 months. Patients with clinician-diagnosed osteoarthritis, rheumatoid arthritis, ankylosing spondylitis or any other condition. 50 years or older or 18-49 with a documented history of gastric or duodenal ulcer within past 5 years. 83% 
    of patients were 50-69 years of age. The prospectively defined primary efficacy endpoint was the cumulative incidence of gastric ulcer<br /> (> 3mm diameter with depth) observed by endoscopy at 1, 3 and 6 months.<sup>1,2</sup>
    
    </i18n>
        </div>
      </div>
      <div class="close"><span class="right"></span></div>
      <div class="arrow_info"></div>
    </div>

</div>
</body>
	<script type="text/javascript" src="../global/js/config.js"></script>
    <script type='text/javascript' src='../framework/steal/steal.production.js?../framework,development'></script>
	
	<script src="resource:js/SystemBridge.js"></script>
	<script type="text/javascript" src="../global/js/havie.js"></script>
    <script type="text/javascript" src="../global/js/global.js"></script>
    <script type="text/javascript" src="../global/js/ref.js"></script>
    <script type="text/javascript" src="javascript/main.js"></script>	
</html>
   